Austin can provide a one-stop solution for Antibody-Drug Conjugates (ADCs) manufacturing from antibody production to in-house toxin-linker CMC services and antibody bioconjugation for drug substance. This is supported by long-term chemical and biological experience. Capabilities also exist to provide cytotoxic fill-finish drug product manufacturing. For more information contact Austin Chemical. #manufacturing #chemical #experience
Austin Chemical is excited to attend TechConnect World Innovation Expo in Washington, DC on June 13-15, 2022. We are happy to discuss our technology and service offerings, logistic support, sourcing and procurement, and contractual distribution services. Please contact Austin Chemical if you would like to set an appointment. #innovation #technology #chemical #procurement #sourcing
Austin Chemical is happy to announce Pharma Tech Outlook has named Cerbios as a Top CMO of 2022. Cerbios is a highly qualified CDMO engaged in the development and manufacturing of API’s, HPAPI’s, ADC’s, and Biologics. For more information on Cerbios’ capabilities please contact Austin Chemical.
Austin Chemical is a long-standing representative of Symeres, a leading European drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). Symeres has recently announced the acquisition of Organix Inc., a US based specialized organic chemistry services provider with a focus on lipids. Please contact Austin Chemical for more information on Symeres…
Austin Chemical is proud to announce Cerbios-Pharma SA, is officially announcing the near finalization of the structure for its new manufacturing building dedicated to High Potency Active Ingredients (HPAPI), which will host 2 additional cGMP production lines for Cytotoxic molecules and additional space for dedicated R&D and QC Labs. Cerbios is active in the HPAPI…
